Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck
Shuya Otsuki, Ryusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, Hisanobu Tamaki, Ryo Asato, Morimasa Kitamura, Kazuyuki Ichimaru, Yoshiharu Kitani, Yohei Kumabe, Keigo Honda, Takashi Tsujimura, Hiroyuki Harada, Koji Ushiro, Koichi Omori
Topics & Concepts
MedicineNivolumabDiscontinuationInternal medicineAdverse effectUnivariate analysisRetrospective cohort studyOncologyProgression-free survivalHead and neck cancerMultivariate analysisSurgeryCancerOverall survivalImmunotherapyHead and Neck Cancer StudiesCancer Immunotherapy and BiomarkersEsophageal Cancer Research and Treatment